POLYPHOR

POLN
Delayed Quote. Delayed  - 01/14 11:31:12 am
1.75CHF -2.23%

Polyphor AG Announces Executive Changes

09/27/2021 | 01:30am
Polyphor AG announced that upon completion of the merger, Andreas Wallnöfer, Silvio Inderbitzin and Hugh O'Dowd will resign as Board members. Upon completion of the merger Juergen Froehlich, Chief Medical Officer at EnBiotix, is nominated as the CMO, replacing Frank Weber, who has decided to leave Polyphor end of October 2021 to pursue other career opportunities. Daniel Obrecht, Chief Scientific Officer of Polyphor, will retire from the company by end of 2021.
© S&P Capital IQ 2022
Copier lien
All news about POLYPHOR AG
12/30
12/30
12/30
12/29
12/29